Does BELANTAMAB MAFODOTIN Cause Basal cell carcinoma? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Basal cell carcinoma have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 0.3% of all adverse event reports for BELANTAMAB MAFODOTIN.
6
Reports of Basal cell carcinoma with BELANTAMAB MAFODOTIN
0.3%
of all BELANTAMAB MAFODOTIN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Basal cell carcinoma From BELANTAMAB MAFODOTIN?
Of the 6 reports, 1 (16.7%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?
Keratopathy (788)
Visual acuity reduced (708)
Death (499)
Plasma cell myeloma (380)
Dry eye (359)
Night blindness (317)
Photophobia (183)
Foreign body sensation in eyes (151)
Vision blurred (134)
Ocular toxicity (94)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which BELANTAMAB MAFODOTIN Alternatives Have Lower Basal cell carcinoma Risk?
BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF
BELANTAMAB MAFODOTIN vs BELATACEPT
BELANTAMAB MAFODOTIN vs BELIMUMAB
BELANTAMAB MAFODOTIN vs BELINOSTAT
BELANTAMAB MAFODOTIN vs BELUMOSUDIL